FDA Inspection 1137148 — Jubilant Generics Limited
The FDA completed an inspection of Jubilant Generics Limited on March 12, 2021 in Bhagwanpur. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 12, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bhagwanpur (India)